Representatives Dr. John Joyce (PA-13) and Scott Peters (CA-50) introduced the bipartisan SECURE 340B Act, the first-ever comprehensive, bipartisan proposal to modernize the 340B Drug Pricing Program since its creation in 1992.
This bill is also cosponsored by Reps. Jake Auchincloss (D-MA), Dan Crenshaw (R-TX), and Nanette Barragán (D-CA). “Since its establishment, the 340B program has served as a critical lifeline for low-income patients to access lifesaving medications,” said Congressman John Joyce, M.D.
The SECURE 340B Act address gaps in the 340B program, such as duplicate discounts, the SECURE 340B Act pauses manufacturer rebate models for four years while a new patient definition is created and standards for contract pharmacies, data sharing, and transparency take effect. It establishes a clear, statutory definition of “patient” based on previous federal guidance. And the bill directs the Health Resources and Services Administration (HRSA) to use an independent, conflict-free clearinghouse to securely manage prescription-level data, verify claims, and protect privacy. It also strengthens HRSA’s authority and provides the transparency and federal guardrails the program has lacked for more than three decades.